Tau PET imaging in Alzheimer's disease
- PMID: 25239654
- DOI: 10.1007/s11910-014-0500-6
Tau PET imaging in Alzheimer's disease
Abstract
In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment. Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression. Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo. For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits. PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration. This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.
Similar articles
-
Advances in the development of tau PET radiotracers and their clinical applications.Ageing Res Rev. 2016 Sep;30:107-13. doi: 10.1016/j.arr.2015.12.010. Epub 2016 Jan 21. Ageing Res Rev. 2016. PMID: 26802556 Review.
-
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography.Curr Neurol Neurosci Rep. 2019 Jun 6;19(7):45. doi: 10.1007/s11910-019-0962-7. Curr Neurol Neurosci Rep. 2019. PMID: 31172290 Free PMC article. Review.
-
Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1605-1617. doi: 10.1007/s00259-018-4012-5. Epub 2018 May 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 29752516 Free PMC article.
-
Characteristics of Tau and Its Ligands in PET Imaging.Biomolecules. 2016 Jan 6;6(1):7. doi: 10.3390/biom6010007. Biomolecules. 2016. PMID: 26751494 Free PMC article. Review.
-
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.Ageing Res Rev. 2017 Jul;36:50-63. doi: 10.1016/j.arr.2017.03.002. Epub 2017 Mar 15. Ageing Res Rev. 2017. PMID: 28315409 Review.
Cited by
-
Feature Importance Analysis and Machine Learning for Alzheimer's Disease Early Detection: Feature Fusion of the Hippocampus, Entorhinal Cortex, and Standardized Uptake Value Ratio.Digit Biomark. 2024 Apr 22;8(1):59-74. doi: 10.1159/000538486. eCollection 2024 Jan-Dec. Digit Biomark. 2024. PMID: 38650695 Free PMC article.
-
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.Brain Commun. 2024 Mar 15;6(2):fcae081. doi: 10.1093/braincomms/fcae081. eCollection 2024. Brain Commun. 2024. PMID: 38505230 Free PMC article.
-
Navigating Early Alzheimer's Diagnosis: A Comprehensive Review of Diagnostic Innovations.Cureus. 2023 Sep 9;15(9):e44937. doi: 10.7759/cureus.44937. eCollection 2023 Sep. Cureus. 2023. PMID: 37818489 Free PMC article. Review.
-
Automated production of 11C-labeled carboxylic acids and esters via "in-loop" 11C-carbonylation using GE FX synthesis modules.J Labelled Comp Radiopharm. 2024 May 30;67(6):217-226. doi: 10.1002/jlcr.4058. Epub 2023 Aug 22. J Labelled Comp Radiopharm. 2024. PMID: 37608567 Free PMC article.
-
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.Free Neuropathol. 2022 Jul 8;3:3-17. doi: 10.17879/freeneuropathology-2022-3806. eCollection 2022 Jan. Free Neuropathol. 2022. PMID: 37284149 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical